Liver Failure Clinical Trials

A listing of Liver Failure medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 209 clinical trials
Randomized Trial of Hepaticojejunostomy Versus Duct-to-duct Anastomosis in Right Lobe Living Donor Liver Transplantation

The scarcity of deceased donor organ supply has driven the practice of living donor liver transplantation (LDLT). Right lobe LDLT (RLDLT) has developed over the last 10 years to extend the benefit of LDLT to adult patients. With technical refinement, the results have significantly improved but bile duct complications remain …

  • 0 views
  • 23 Jan, 2021
  • 1 location
RCA for CRRT in Liver Failure and High Risk Bleeding Patients

The purpose of this single center, randomized, control, open-labeled study is to evaluate the effect and safety of RCA versus no anticoagulation for CRRT in patients with liver failure and high

  • 0 views
  • 22 Jan, 2021
  • 1 location
Hepato Biliary Scintigraphy to Assess the Risk of Postoperative Liver Failure Hepatectomies

Extended hepatectomies of 4 or more segments are complicated by high rates of morbidity and mortality, mainly related to hepatic liver failure. Nowadays, preoperative assessment of the future

scintigraphy
hepatectomy
  • 3 views
  • 26 Jan, 2021
  • 13 locations
Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit

. Early physical rehabilitation has shown benefit in ICU settings, but has not been studied in ICU patients with acute and chronic liver failure. Cycle ergometry, or stationary cycling in passive and

liver disease
  • 0 views
  • 16 May, 2021
  • 1 location
Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia

End stage liver disease is prone to thrombocytopenia. This study is a multi-center, randomized, prospective, randomized controlled Phase IV Clinical trial to discuss the Efficacy and Safety of Avatrombopag in Patients with End-stage Liver Disease and Thrombocytopenia.

liver disease
platelet count
avatrombopag
cirrhosis
  • 0 views
  • 16 Jun, 2021
  • 1 location
Efficacy Safety And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy

The purpose of the study is to evaluate the safety of Rifaximin or placebo in subjects with severe hepatic impairment and Hepatic Encephalopathy.

liver disease
rifaximin
  • 270 views
  • 26 Jan, 2021
  • 28 locations
Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial)

Hepatic Encephaopathy is a common complication occurring in patients with Liver cirrhosis. Patients usually develop mild confusion, sleep disturbance or obtundation. It occurs due to accumulation of excess ammonia in the brain, as the liver is unable to metabolize the ammonia. The common gold standard treatment recommended for patients with …

antibiotics
asterixis
bloating
encephalopathy
confusion
  • 114 views
  • 18 Jul, 2021
  • 1 location
Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy

Efficacy and Safety of Nitazoxanide in preventing recurrence of Hepatic Encephalopathy.

rifaximin 550 mg
rifaximin
  • 4 views
  • 23 Jan, 2021
  • 1 location
Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy

Readmission rates for patients with hepatic encephalopathy due to end stage liver disease are high. Hyperammonemia contributes significantly to encephalopathy and occurs because of impaired hepatic ureagenesis and increased skeletal muscle proteolysis. We propose a randomized, 6-month nutritional intervention in cirrhotic patients who have had at least 1 admission for …

ct scan
hyperammonemia
encephalopathy
protein supplement
liver disease
  • 38 views
  • 26 Aug, 2021
  • 1 location
Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

This is a global study to compare the effects of AXA1665, an orally active mixture of amino acids, compared to placebo, on cognitive and physical function, as well as the safety and tolerability of AXA1665.

cirrhosis
screening procedures
encephalopathy
  • 0 views
  • 24 Sep, 2021
  • 13 locations